Medtronic plc (MDT) FY2026 Financials
PeriodQ1 FY2027FY2026
Archived record for FY2026. The current period is Q1 FY2027.
Published
Medtronic reported $36.36 billion in revenue for FY2026, the fiscal year ended April 24, 2026, up 8.4% from a year earlier, with net income attributable to Medtronic of $4.80 billion and diluted earnings per share of $3.73. Operating profit was $6.47 billion, up 8.6%, keeping pace with sales, while net income grew more slowly as a higher effective tax rate absorbed much of the operating gain. Free cash flow was $5.43 billion, up 4.6%, in a year when Medtronic listed its Diabetes business as MiniMed Group and retained a controlling stake in it.
| Metric | Amount | vs. year ago |
|---|---|---|
| Revenue | $36,364,000,000 | up 8.4% |
| Net income | $4,801,000,000 | up 3.0% |
| Diluted EPS | $3.73 | up 3.3% |
| Operating profit | $6,467,000,000 | up 8.6% |
| Free cash flow | $5,426,000,000 | up 4.6% |
Company details
| Name | Medtronic plc |
|---|---|
| Ticker | MDT |
| CIK | 0001613103 |
| Exchange | NYSE |
| SIC | 3845 |
| Office | Industrial Applications and Services |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Latest period covered | FY2026, ended 2026-04-24, 10-K, accession 0001628280-26-044354 |
| Fiscal year end | 04/24 (MM/DD) |
Data files
- Financial statementsPage Annual financial statements plus the latest quarter: income statement, balance sheet, cash flow. Actual dollars, actual shares. Sourcing notes and uncertainties included.
- 10-K and 10-Q summaryPage Qualitative synthesis of the latest 10-K + 10-Q: business, risk factors (quarter-over-quarter changes flagged), MD&A, legal proceedings, subsequent events.
- 8-K filings and eventsPage Digest of material 8-K filings: earnings headlines, management changes, capital-return and financing actions, governance. SEC accession numbers cited throughout.
FAQ · Medtronic FY2026
How much revenue did Medtronic report in FY2026?
Medtronic reported $36.36 billion in revenue for FY2026, the fiscal year ended April 24, 2026. That is up 8.4% from $33.54 billion a year earlier, led by the Cardiovascular portfolio, which supplied most of the increase, with the Neuroscience and Medical Surgical portfolios growing more slowly and the smaller Diabetes business growing fastest.
How much profit did Medtronic make in FY2026?
Net income attributable to Medtronic was $4.80 billion for FY2026, up 3.0% from $4.66 billion a year earlier. Operating profit was $6.47 billion, up 8.6%, and the slower growth in net income reflects a higher effective tax rate rather than weaker operations.
What was Medtronic's earnings per share in FY2026?
Medtronic reported diluted earnings per share of $3.73 for FY2026, the fiscal year ended April 24, 2026, up 3.3% from $3.61 a year earlier.
How much free cash flow did Medtronic generate in FY2026?
Medtronic generated $5.43 billion of free cash flow in FY2026, up 4.6% from $5.18 billion a year earlier. Free cash flow here is operating cash flow less additions to property, plant, and equipment, which is Medtronic's own definition.
Where can I get Medtronic plc (MDT) financial data in machine-readable form?
Ticker Scout publishes Medtronic plc's financial statements as JSON at https://tickerscout.ai/mdt/financials.json, free, with no API key and no signup. The 10-K and 10-Q narrative and the 8-K events digest are published as Markdown at https://tickerscout.ai/mdt/narrative.md and https://tickerscout.ai/mdt/events.md. Medtronic plc's SEC CIK is 0001613103. Every figure cites the SEC accession number it came from, so it can be checked against sec.gov.
Related companies
How this page was built
This page was built from Medtronic plc's own filings with the SEC, read one at a time, and nothing on it is taken from a pre-tagged dataset, a data vendor or another website. The figures are on the company's own fiscal calendar and in actual dollars, as the filings report them. Where the filings do not support a figure, the record says so instead of reporting a zero; this period names four such gaps.
A single company files thousands of pages with the SEC in a year, and no two companies file them the same way, so the reading and the assembly here are done by AI rather than by rules that break on the differences. Every pass is then audited back against the filings it came from before the page is published, and anything the filings do not support is left out and named rather than filled in. AI can still make mistakes. That is why the accession numbers are printed: the filing is the authority, and this page is a route to it.
Published by Ticker Scout, an independent publisher of company filings data. About Ticker Scout · Disclaimer
Data extracted from SEC filings (accession numbers cited in each file). The undated URLs hold the latest period and are replaced in place each quarter; every period also stays published at its own dated URL, which never changes. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.